Becton Dickinson and CoNYSE:BDX
- LAST PRICE233.4213
- TODAY'S CHANGE (%)-3.5287 (-1.4892%)
- Bid / Lots233.3800/ 1
- Ask / Lots233.8300/ 4
- Open / Previous Close236.5400 / 236.9500
- Day Range
- 52 Week Range
- Volume204,476
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BDX |
|---|---|---|
| 09:32 ET | 14469 | 236.63 |
| 09:34 ET | 2740 | 235.67 |
| 09:36 ET | 4884 | 236.05 |
| 09:38 ET | 1408 | 235.17 |
| 09:39 ET | 3790 | 235 |
| 09:41 ET | 1497 | 234.24 |
| 09:43 ET | 2877 | 234.755 |
| 09:45 ET | 3826 | 234.44 |
| 09:48 ET | 1400 | 233.77 |
| 09:50 ET | 3330 | 234.25 |
| 09:52 ET | 3043 | 233.32 |
| 09:54 ET | 1900 | 233.47 |
| 09:56 ET | 4057 | 233.45 |
| 09:57 ET | 2100 | 233.24 |
| 09:59 ET | 4670 | 232.89 |
| 10:01 ET | 3298 | 233.3004 |
| 10:03 ET | 2155 | 233.5 |
| 10:06 ET | 601 | 233.08 |
| 10:08 ET | 4640 | 233.37 |
| 10:10 ET | 1075 | 233.08 |
| 10:12 ET | 400 | 233.38 |
| 10:14 ET | 469 | 233.09 |
| 10:15 ET | 2603 | 233.4213 |
Sep 18, 2024
BD Expands Capacity for Advanced Prefillable Syringes and Enhances Injection Experience for the Next Generation of Biologics, from 6:50AM ET on Wednesday Sep 18, 2024 by Dow Jones
6:50AM ET on Wednesday Sep 18, 2024 by Dow Jones
Sep 3, 2024
BD Completes Acquisition of Critical Care from Edwards Lifesciences, from 4:30PM ET on Tuesday Sep 03, 2024 by Dow Jones
4:30PM ET on Tuesday Sep 03, 2024 by Dow JonesPress Release: BD Completes Acquisition of Critical Care from Edwards Lifesciences, from 4:30PM ET on Tuesday Sep 03, 2024 by Dow Jones
4:30PM ET on Tuesday Sep 03, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Becton Dickinson and Co | 68.5B | 46.5x | +11.04% |
IDEXX Laboratories Inc | 41.7B | 50.0x | +18.62% |
Baxter International Inc | 19.9B | -125.0x | --- |
Mettler-Toledo International Inc | 30.6B | 39.5x | +12.39% |
Dexcom Inc | 27.5B | 42.2x | --- |
Zimmer Biomet Holdings Inc | 22.0B | 22.2x | --- |
Company Information
Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring solutions and pharmaceutical systems. The Company's BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
Contact Information
- Headquarters
- One Becton DriveFRANKLIN LAKES, NJ, United States 07417-1880
- Phone
- 201-847-6800
- Fax
- ---
Executives
- Chairman of the Board, President, Chief Executive Officer
- Thomas Polen
- Chief Financial Officer, Executive Vice President
- Christopher DelOrefice
- Chief People Officer, Executive Vice President
- Shana Neal
- Executive Vice President, President, North America, Chief Marketing Officer
- Antoine Ezell
- Executive Vice President, General Counsel
- Michelle Quinn
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $68.5B |
|---|---|
Revenue (TTM) | $19.8B |
Shares Outstanding | 289.0M |
Dividend Yield | 1.63% |
Annual Dividend Rate | 3.8000 USD |
Ex-Dividend Date | 09-09-24 |
Pay Date | 09-30-24 |
Beta | 0.43 |
EPS | $5.01 |
Book Value | $88.83 |
P/E Ratio | 46.5x |
Price/Sales (TTM) | 3.5 |
Price/Cash Flow (TTM) | 18.3x |
Operating Margin | 11.01% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
